Exploring KRAS-mutant pancreatic ductal adenocarcinoma: a model validation study

Overview of attention for article published in Frontiers in immunology, January 2024

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 1 X post from an account with 32,876 followers.

New Research: Exploring KRAS-mutant pancreatic ductal adenocarcinoma: a model validation study: Introduction Pancreatic ductal adenocarcinoma (PDAC) has the highest mortality rate among all solid tumors. Tumorigenesis is promoted by the… https://t.co/Qa2i

10 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.